Free shipping on all orders over $ 500

PD 169316

Cat. No. M2583
PD 169316 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
5mg USD 55  USD55 In stock
10mg USD 85  USD85 In stock
50mg USD 240  USD240 In stock
100mg USD 365  USD365 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PD 169316 is a cell-permeable, potent and selective p38 MAP kinase inhibitor that indirectly activates proteasome activity and has antiviral activity against Enterovirus71 with an IC50 value of 89 nM.

Customer Product Validations & Biological Datas
Source Oncol Lett (2018). Figure 7. PD169316
Method CCK‑8 assay
Cell Lines NB4 cells
Concentrations 10 μM
Incubation Time 24 h
Results The results of the CCK‑8 assay showed that PD169316 could partially reverse the growth inhibition induced by lapatinib treatment.
Chemical Information
Molecular Weight 360.34
Formula C20H13FN4O2
CAS Number 152121-53-4
Solubility (25°C) DMSO 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Fu Y, et al. Biochem Biophys Res Commun. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.

[2] Nath R, et al. Cell Mol Biol Lett. Inhibition of p38 kinase mimics survival signal-linked protection against apoptosis in rat cerebellar granule neurons.

Related p38 MAPK Products
HWY336

HWY336 is a selective, non-ATP competitive dual MKK4 and MKK7 inhibitor with IC50 values of 6 µM on MKK4 and 10 µM on MKK7 in vitro. HWY336 inhibits the phosphorylation of MKK4/MKK7 inside the activation loop or hinders the substrate to access the kinase.

BSJ-04-122

BSJ-04-122 is a covalent MKK4/7 dual inhibitor. BSJ-04-122 inhibits MKK4 and MKK7 with IC50 values of 4 nM and 181 nM, respectively.

OVA-E1 peptide TFA

OVA-E1 peptide TFA, is an antagonist variant of SIINFEKL [OVA (257-264).

MBP MAPK Substrate

MBP MAPK Substrate is used as an exogenous substrate for MAPK.

OVA-E1 peptide

OVA-E1 peptide, is an antagonist variant of SIINFEKL [OVA (257-264).

  Catalog
Abmole Inhibitor Catalog




Keywords: PD 169316 supplier, p38 MAPK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.